Products & Services · Revenues:

Comirnaty — Revenues:

Pfizer Comirnaty — Revenues: decreased by 89.8% to $232.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.9%, from $565.00M to $232.00M. Over 4 years (FY 2021 to FY 2025), Comirnaty — Revenues: shows a downward trend with a -41.3% CAGR.

Analysis

StatementSegment
First reportedQ1 2019
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_comirnaty_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.84B$12.98B$12.50B$13.23B$8.85B$4.40B$11.33B$3.06B$1.49B$1.31B$5.36B$354.00M$195.00M$1.42B$3.38B$565.00M$381.00M$1.15B$2.27B$232.00M
QoQ Change—+65.6%-3.6%+5.8%-33.1%-50.2%+157.4%-73.0%-51.4%-12.2%+310.6%-93.4%-44.9%+629.2%+137.9%-83.3%-32.6%+202.1%+97.2%-89.8%
YoY Change————+12.9%-66.1%-9.4%-76.8%-83.2%-70.3%-52.7%-88.4%-86.9%+8.9%-36.9%+59.6%+95.4%-19.1%-32.9%-58.9%
Range$195.00M – $13.23B
CAGR-52.3%
Avg YoY Growth-31.6%
Median YoY Growth-44.8%

Frequently Asked Questions

What is Pfizer's comirnaty — revenues:?
Pfizer (PFE) reported comirnaty — revenues: of $232.00M in Q1 2026.
How has Pfizer's comirnaty — revenues: changed year-over-year?
Pfizer's comirnaty — revenues: decreased by 58.9% year-over-year, from $565.00M to $232.00M.
What is the long-term trend for Pfizer's comirnaty — revenues:?
Over 4 years (2021 to 2025), Pfizer's comirnaty — revenues: has grown at a -41.3% compound annual growth rate (CAGR), from $36.78B to $4.37B.